CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −9,459 | $1.82 | $17K | 2,454,775 |
| 2023-04-12 | ORBIMED ADVISORS LLC 10% owner | Sale | −119 | $1.81 | $215 | 183,207 |
| 2023-04-12 | ORBIMED ADVISORS LLC 10% owner | Sale | −641 | $1.81 | $1K | 985,647 |
| 2023-04-12 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,603 | $1.81 | $3K | 2,464,234 |
| 2023-04-11 | ORBIMED ADVISORS LLC 10% owner | Sale | −703 | $1.82 | $1K | 183,326 |
| 2023-04-11 | ORBIMED ADVISORS LLC 10% owner | Sale | −3,784 | $1.82 | $7K | 986,288 |
| 2023-04-11 | ORBIMED ADVISORS LLC 10% owner | Sale | −9,459 | $1.82 | $17K | 2,465,837 |
| 2023-04-10 | ORBIMED ADVISORS LLC 10% owner | Sale | −2,584 | $1.79 | $5K | 185,910 |
| 2023-04-10 | ORBIMED ADVISORS LLC 10% owner | Sale | −13,899 | $1.79 | $25K | 1,000,187 |
| 2023-04-10 | ORBIMED ADVISORS LLC 10% owner | Sale | −34,745 | $1.79 | $62K | 2,500,582 |
| 2023-04-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −487 | $2.00 | $974 | 186,613 |
| 2023-04-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −2,620 | $2.00 | $5K | 1,003,971 |
| 2023-04-06 | ORBIMED ADVISORS LLC 10% owner | Sale | −6,558 | $2.00 | $13K | 2,510,041 |
| 2023-04-05 | ORBIMED ADVISORS LLC 10% owner | Sale | −4,687 | $2.18 | $10K | 187,100 |
| 2023-04-05 | ORBIMED ADVISORS LLC 10% owner | Sale | −25,220 | $2.18 | $55K | 1,006,591 |
| 2023-04-05 | ORBIMED ADVISORS LLC 10% owner | Sale | −63,058 | $2.18 | $137K | 2,516,599 |
| 2023-01-04 | Schambye Hans T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2023-01-04 | Pedersen Anders Chief Operating Officer | Grant or award · Stock Option (right to buy) | +115,000 | 115,000 | ||
| 2023-01-04 | Winslow Garrett General Counsel | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2023-01-04 | Oestreich Stephanie Chief Business Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 |
Page 6 of 12 · 227 trades